Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.

Abstract

The APhL ELISA Kit appears to be more specific than the standard aCL ELISA without adding potential false positive results. The new test may be useful for followup study for patients found to be aCL positive by standard assays to increase specificity for aCL screening.